Abstract:Background: Chronic cyclosporine A (CsA) nephropathy is a well described side effect of CsA treatment. CsA has been shown to induce the synthesis of extracellular matrix (ECM) proteins in mesangial cells (MCs) in vitro, and glomerulosclerosis in vivo. Transforming growth factor-beta1 (TGF-beta1) is a potent stimulus for the synthesis of ECM proteins in MCs. We investigated whether CsA up-regulates the expression of TGF-beta1 and its receptors type I (TbetaR-I) and type II (TbetaR-II) in cultured rat MCs, and whether this effect translates into enhanced matrix protein accumulation. Methods: Resting MCs were incubated in the presence or absence of CsA and anti-TGF-beta1 antibodies. Time- and concentration-dependent expression of TGF-beta1, TbetaR-I and TbetaR-II were measured at both the mRNA (competitive reverse transcription PCR) and protein level (enzyme-linked immunosorbent assay (ELISA) and western blotting). Fibronectin (FN) and plasminogen activator inhibitor type-1 (PAI-1) synthesis were measured by ELISA. Results: Compared with untreated controls, CsA stimulated mRNA production of TGF-beta1 (maximum at 72 h, 500 ng/ml CsA: 2.1+/-0.5-fold, P<0.001) and TbetaR-II (maximum at 72 h, 1000 ng/ml CsA: 2.4+/-0.4-fold, P<0.005) time- and dose-dependently. TbetaR-I mRNA concentrations remained unchanged. Protein concentrations were analysed at 96 h: TGF-beta1, 220+/-32 vs 86+/-24 pg/ml, P<0.001 (500 ng/ml CsA vs control); TbetaR-I, 2.0+/-0.5-fold, P<0.005 (1000 ng/ml CsA vs control); TbetaR-II, 2.5+/-0.7-fold, P<0.05 (1000 ng/ml CsA vs control). CsA (500 ng/ml) also enhanced the production of FN (1.6-fold, P<0.05) and PAI-1 (2.0-fold, P<0.05). Co-incubation with neutralizing anti-TGF-beta1 antibodies reduced (P<0.05) CsA-induced expression of TbetaR-I (1.0+/-0.1-fold), TbetaR-II (1.3+/-0.1-fold) and PAI-1 (1.3-fold), but not FN production (1.6-fold). Conclusions: Pharmacologically relevant concentrations of CsA time- and dose-dependently up-regulate the expression of TGF-beta1 and, via autocrine mechanisms, its receptors type I and II in rat MCs. Whereas up-regulation of PAI-1 is mediated by TGF-beta1, up-regulation of FN is-at least in part-either directly induced by CsA or mediated by factors other than TGF-beta1.

Different effects of CsA and FK506 on aquaporin-2 abundance in rat primary cultured collecting duct cells

Long-term Treatment with Cyclosporine Decreases Aquaporins and Urea Transporters in the Rat Kidney.

Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.

Cyclosporine A protects podocytes via stabilization of cofilin-1 expression in the unphosphorylated state.

Activation of Kir4.1/Kir5.1 Contributes to the Cyclosporin A‐induced Stimulation of the Renal NaCl Cotransporter and Hyperkalemic Hypertension

[Effects of Cyclosporin A on Gene Expression Profiles of NIT-1 Pancreatic Beta Cell Line].

Electrophysiological Actions of Cyclosporin A and Tacrolimus on Rat Hippocampal CA1 Pyramidal Neurons

Expression of Angiotensin II and Its Receptors in a Rat Model of Chronic Cyclosporine Nephrotoxicity

Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells

Cyclosporine Stimulates the Renal Epithelial Sodium Channel by Elevating Cholesterol

Cyclosporine A Protects Podocytes by Regulating Transgelin in Adriamycin-Induced Podocyte Injury

Cyclosporin A Enhances the Calcium-Dependent Induction of AP-1 Complex and C-Fos Mrna in a T Cell Lymphoma.

Modulation of Calcineurin Activity in Mouse Brain by Chronic Oral Administration of Cyclosporine A.

Cyclosporin A inhibits creatine uptake by altering surface expression of the creatine transporter

Cyclosporin A Disrupts Bradykinin Signaling Through Superoxide.

Effects of cyclosporin A, FK506 and rapamycin on calcineurin phosphatase activity in mouse brain.

Cyclosporin A Inhibits the Activation of Membrane-Bound Guanylate Cyclase GC-A of Atrial Natriuretic Factor via NAD(P)H Oxidase

The Regulatory Domains of Cna Have Different Effects on the Inhibition of Cn Activity by Fk506 and Csa

Phosphatase Inhibition Increases Aqp2 Accumulation in the Rat Imcd Apical Plasma Membrane

Cyclosporine A protects podocytes by regulating WAVE1 phosphorylation

Therapeutic Effects of FK506 on IgA Nephropathy Rat